PPP1R12A and colorectal carcinoma: In this study, we employed the quantitative PCR to detect the relative copy number (RCN) of PPP1R12A in stage III CRC patients receiving oxaliplatin-based regimen and compute the association of PPP1R12A gene copy number with clinical outcomes.